China Solar Energy warns of loss

No thanks to impairment loss.

Based on a preliminary review on the management accounts of China Solar Energy Holdings Limited and its subsidiaries, the board of directors of the company announced that it is expected that the Group will record a substantial loss for the six months ended 30 September 2012 as compared to a loss for the six months ended 30 September 2011.

The forecast substantial loss, based on the information currently available, is mainly attributable to the impairment loss to be recognised in respect of the goodwill arising from the acquisition of the subsidiaries and the intangible assets, which represented certain technologies and intellectual property rights related to the photovoltaic business, and the share based payment expenses in respect of the share options granted.

The Group is in the process of finalising its interim results.

Follow the link for more news on

Join Hong Kong Business community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

Hong Kong and Shanghai to enhance financial ties
The two cities will leverage on their competitive advantage to boost their financial cooperation.
HK Express load factors exceed 97% in April amidst Easter holidays
Current bookings to North Asian destinations exceed 90% occupancy as Golden Week approaches.
Aviation
PolyU partners with ZEISS for myopia control tech advancement
The partnership focuses on developing myopia control and other ophthalmic technologies.
Healthcare